Carbon-ion radiotherapy for marginal lymph node recurrences of cervical cancer after definitive radiotherapy: a case report

被引:5
|
作者
Tamaki, Tomoaki [1 ]
Ohno, Tatsuya [1 ]
Kiyohara, Hiroki [1 ]
Noda, Shin-ei [1 ]
Ohkubo, Yu [1 ]
Ando, Ken [1 ]
Wakatsuki, Masaru [2 ]
Kato, Shingo [3 ]
Kamada, Tadashi [2 ]
Nakano, Takashi [1 ]
机构
[1] Gunma Univ, Grad Sch Med, Dept Radiat Oncol, Maebashi, Gunma 3718511, Japan
[2] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Inage Ku, Chiba 2638555, Japan
[3] Saitama Med Univ Int Med Ctr, Hidaka, Saitama 3501298, Japan
关键词
Carbon-ion radiotherapy; Marginal recurrences; Cervical cancers; RADIATION-THERAPY; UPDATE;
D O I
10.1186/1748-717X-8-79
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recurrences of cervical cancer after definitive radiotherapy often occur at common iliac or para-aortic lymph nodes as marginal lymph node recurrences. Patients with these recurrences have a chance of long-term survival by optimal re-treatment with radiotherapy. However, the re-irradiation often overlaps the initial and the secondary radiotherapy fields and can result in increased normal tissue toxicities in the bowels or the stomach. Carbon-ion radiotherapy, a form of particle beam radiotherapy using accelerated carbon ions, offers more conformal and sharp dose distribution than X-ray radiotherapy. Therefore, this approach enables the delivery of high radiation doses to the target while sparing its surrounding normal tissues. Marginal lymph node recurrences in common iliac lymph nodes after radiotherapy were treated successfully by carbon-ion radiotherapy in two patients. These two patients were initially treated with a combination of external beam radiotherapy and intracavitary and interstitial brachytherapy. However, the diseases recurred in the lymph nodes near the border of the initial radiotherapy fields after 22 months and 23 months. Because re-irradiation with X-ray radiotherapy may deliver high doses to a section of the bowels, carbon-ion radiotherapy was selected to treat the lymph node recurrences. A total dose of 48 Gy (RBE) in 12 fractions over 3 weeks was given to the lymph node recurrences, and the tumors disappeared completely with no severe acute toxicities. The two patients showed no evidence of disease for 75 months and 63 months after the initial radiotherapy and for 50 months and 37 months after the carbon-ion radiotherapy, respectively. No severe late adverse effects are observed in these patients. The two presented cases suggest that the highly conformal dose distribution of carbon-ion radiotherapy may be beneficial in the treatment of marginal lymph node recurrences after radiotherapy. In addition, the higher biological effect of carbon-ion radiotherapy and its superior dose distribution may provide more effective tumor control in treatment for re-irradiation of the marginal recurrences in radiation resistant tumors other than cervical cancer.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Carbon ion radiotherapy for bladder cancer: A case report
    Zhang, Yan-Shan
    Li, Xiao-Jun
    Zhang, Yi-He
    Hu, Ting-Chao
    Chen, Wei-Zuo
    Pan, Xin
    Chai, Hong-Yu
    Wang, Xin
    Yang, Yu-Ling
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (26) : 7833 - 7839
  • [22] Prognostic Factors of Flap Complications After Carbon-ion Radiotherapy for Head and Neck Cancer With Reconstruction
    Ikawa, Hiroaki
    Koto, Masashi
    Omatsu, Tokuhiko
    Aoki, Shuri
    Takiyama, Hirotoshi
    Isozaki, Tetsuro
    Shinoto, Makoto
    Imai, Reiko
    Tsuji, Hiroshi
    Yamada, Shigeru
    ANTICANCER RESEARCH, 2024, 44 (12) : 5569 - 5576
  • [23] Predictors of Outcomes in Patients With Clinically Lymph Node Positive Prostate Cancer After Definitive Radiotherapy
    Kim, Tae Hyun
    Kim, Dong-Yun
    Kim, Jae-Sung
    IN VIVO, 2023, 37 (05): : 2365 - 2370
  • [24] Conversion surgery for an initially unresectable, locally advanced pancreatic cancer after induction chemotherapy and carbon-ion radiotherapy: a case report
    Fujishiro, Takeshi
    Mashiko, Taro
    Masuoka, Yosihito
    Yamada, Misuzu
    Furukawa, Daisuke
    Yazawa, Naoki
    Kawashima, Yohei
    Ogawa, Masami
    Hirabayashi, Kenichi
    Nakagohri, Toshio
    SURGICAL CASE REPORTS, 2018, 4
  • [25] Conversion surgery for an initially unresectable, locally advanced pancreatic cancer after induction chemotherapy and carbon-ion radiotherapy: a case report
    Takeshi Fujishiro
    Taro Mashiko
    Yosihito Masuoka
    Misuzu Yamada
    Daisuke Furukawa
    Naoki Yazawa
    Yohei Kawashima
    Masami Ogawa
    Kenichi Hirabayashi
    Toshio Nakagohri
    Surgical Case Reports, 4 (1)
  • [26] Primary spindle cell sarcoma of the heart treated with carbon-ion radiotherapy: Case report
    Shibasaki, Ikuko
    Toyoda, Shigeru
    Takei, Yusuke
    Chida, Masayuki
    Fukuda, Hirotsugu
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2020, 76 : 1 - 4
  • [27] Carbon-ion re-irradiation for recurrences after initial treatment of stage I non-small cell lung cancer with carbon -ion radiotherapy
    Karube, Masataka
    Yamamoto, Naoyoshi
    Tsuji, Hiroshi
    Kanematsu, Nobuyuki
    Nakajima, Mio
    Yamashita, Hideomi
    Nakagawa, Keiichi
    Kamada, Tadashi
    RADIOTHERAPY AND ONCOLOGY, 2017, 125 (01) : 31 - 35
  • [28] Carbon-ion Radiotherapy for Oligometastatic Colorectal Cancer in the Liver or Lung
    Shiba, Shintaro
    Shibuya, Kei
    Okamoto, Masahiko
    Okano, Naoko
    Kubo, Nobuteru
    Kaminuma, Takuya
    Sato, Hiro
    Okazaki, Shohei
    Miyasaka, Yuhei
    Kawamura, Hidemasa
    Ohno, Tatsuya
    ANTICANCER RESEARCH, 2021, 41 (04) : 1997 - 2005
  • [29] Carbon ion radiotherapy as definitive treatment in locally recurrent pancreatic cancer
    Liermann, Jakob
    Ben-Josef, Edgar
    Syed, Mustafa
    Debus, Juergen
    Herfarth, Klaus
    Naumann, Patrick
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (04) : 378 - 387
  • [30] Treatment of lymph node metastatic melanoma with carbon ion radiotherapy
    Fujita, Hiroyuki
    Wada, Hidefumi
    Koiwa, Katsuji
    Yasumura, Kazunori
    Kamada, Tadashi
    Ikezawa, Zenro
    EUROPEAN JOURNAL OF DERMATOLOGY, 2009, 19 (03) : 277 - 278